Independent association of angiogenesis index with outcome in prostate cancer

Clinical Cancer Research

Volumn 7, Issue 1, 2001, Pages 81-88

  Mehta, Rita ^a   Kyshtoobayeva, Ainura ^a   Kurosaki, Tom ^b   Small, Eric J ^c   Kim, Hun ^d   Stroup, Robert ^d   McLaren, Christine E ^b   Li, Kuo Tung ^b   Fruehauf, John P ^a  

^a Oncotech Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Western Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; THROMBOSPONDIN 1;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; DISEASE COURSE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA;

ADENOCARCINOMA; AGED; ANTIGENS, CD31; BIOPSY, NEEDLE; DISEASE PROGRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; MALE; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PARAFFIN EMBEDDING; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035138955     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. The use of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer: A multi-institutional update
2. The combination of preoperative prostate-specific antigen and postoperative pathological findings to predict prostate-specific antigen outcome in clinically localized prostate cancer
3. Alteration of the tumor suppressor gene in a high fraction of hormone refractory prostate cancer
4. p53 Nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy
5. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation
6. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate
7. Expression of thrombospondin-1 and p53 in human pancreatic adenocarcinomas
8. Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression
9. Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis and metastatic progression in melanoma
10. Mutant p53, TSP-1, and angiogenesis: An index of metastatic risk in breast cancer
11. P53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein
12. Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers
13. Biomarker conservation in primary and metastatic epithelial ovarian cancer
14. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
15. Nonparametric estimation from incomplete observations
16. Tumor angiogenesis
17. Quantitative microvessel density. A staging and prognostic marker for human prostatic carcinoma
18. Apoptosis and angiogenesis: Two promising tumor markers in breast cancer
19. How tumors become angiogenic
20. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells
21. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis
22. Alterations in tumor suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells
23. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma
24. Expression of the extracellular matrix protein molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma cell lines
25. SPARC and thrombospondin genes are repressed by c-jun oncogene in rat embryo fibroblasts
26. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1
27. Thrombospondins I and II messenger RNA expression in lung carcinoma: Relationship with p53 alterations, angiogenic growth factors, and vascular density
28. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization
29. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathological stage in Gleason sum 5 to 7 adenocarcinoma of the prostate
30. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy
31. Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer